INTRODUCTION
============

Tobacco/cigarette smoking causes 6 million deaths every year ([@b48-bt-22-460]). Adding alarm is the consistent increase in the number of smokers around the world ([@b20-bt-22-460]). Because of this immense threat to public health, various efforts have been made to curb this problem ([@b15-bt-22-460]; [@b41-bt-22-460]). One vital step is to understand why tobacco/cigarettes are so addictive. Substantial evidences have implicated that nicotine is the primary addictive component in tobacco ([@b9-bt-22-460]). Nicotine is an alkaloid found in abundant amounts in tobacco leaf ([@b31-bt-22-460]; [@b34-bt-22-460]). Nicotine produces strong positive effects on mood and cognition, which directly contribute to the development of addiction ([@b22-bt-22-460]; [@b26-bt-22-460]).

Although nicotine is generally acknowledged to produce positive rewarding and reinforcing, demonstrating these effects in animal models has proven to be difficult ([@b16-bt-22-460]). Animal models are essential in understanding and managing addiction because it bypasses the ethical and methodological concerns associated with human studies ([@b17-bt-22-460]; [@b3-bt-22-460]). Two of the most widely used and accepted animal models of drug addiction are the conditioned place preference (CPP) and self-administration (SA) tests ([@b43-bt-22-460]; [@b39-bt-22-460]). The CPP test has been used for assessing addiction-related behaviors and considered to quantify the rewarding effects (hedonic value) of a substance ([@b7-bt-22-460]) whereas the SA test, believed to be the most valid animal model of addiction, measures drug-seeking and drug taking behavior (reinforcing effects) ([@b46-bt-22-460]). When a substance produces both CPP and SA, then it is likely that the substance may have high addictive liability.

Previous nicotine CPP and SA studies have reported somewhat inconsistent results. Some have successfully produced nicotine CPP and SA while others did not ([@b21-bt-22-460]; [@b3-bt-22-460]). Those who have established nicotine CPP and SA also have discrepant findings, mostly associated with the methodological differences (e.g. route of administration, dosages used, and age of the subjects) ([@b21-bt-22-460]). Because of these, there are no standard or established protocol for nicotine CPP and SA.

Thus, in the present study we sought to characterize the rewarding and reinforcing effects of nicotine through the CPP and the SA tests. Nicotine CPP and SA were evaluated across a wide dose range, in both adolescent and adult rats. The difference between the i.p. and the s.c. route was also tested for nicotine CPP.

MATERIALS AND METHODS
=====================

Subjects
--------

Male Sprague-Dawley adolescent \[postnatal day (PND) 21\] and adult rats (PND 56), were obtained from Hanlim Animal Corporation (Hwasung, Korea). They were caged in groups (conditioned place preference) or individually (self-administration) in temperature- (22 ± 2°C) and humidity- (55 ± 5%) controlled animal room on a 12 h/12 h light/dark (7 AM--7 PM) schedule. Food and water were freely accessible, except on days when they undergone lever training. All rats were acclimated to their home cages for at least 3 days before the commencement of any tests. Eight to ten rats were chosen for each group. Animal treatment and maintenance were carried out in accordance with the Principles of Laboratory Animal Care (NIH publication no. 85-23 revised 1985) and the Animal Care and Use Guidelines of Sahmyook University, Korea.

Drugs
-----

(−)Nicotine hydrogen tartrate salt (Sigma) was dissolved in physiologic saline, with pH adjusted to 7.3 ± 0.1, then administered at 1 ml/kg of body weight. Nicotine dosages are reported as the free base.

Conditioned place preference (CPP) test
---------------------------------------

A two-compartment place preference apparatus made of polyvinylchloride was used. Each of the compartments (measuring 47 cm×47 cm×47 cm) had unique visual and tactile cues, that is, one side was dark with a smooth floor and the other side had white dotted walls and a rough, black floor. A guillotine door divided the apparatus and served as a partition between the compartments during the conditioning phase. Ethovision (Noldus, Netherlands) system was used to record animal movement and behavior.

The CPP test was performed in accordance to previous studies with slight modification ([@b2-bt-22-460]; [@b10-bt-22-460]; [@b11-bt-22-460]; [@b12-bt-22-460]). A biased CPP design was employed based on the recommendation of ([@b21-bt-22-460]). The test is comprised of three phases: (1) habituation and preconditioning, (2) conditioning, and (3) post-conditioning. During the first (preconditioning) phase, the guillotine door was opened to allow each rat free access to both compartments for 15 minutes, once a day for three days. On third day, the time spent by rats in both sides of the box was measured using an automated video tracking system \[EthoVision (Noldus IT b.v. Netherlands)\] to determine their preferred and non-preferred sides. During the second (conditioning) phase, the guillotine door was closed. The initially preferred side was paired with saline and non-preferred side was paired with nicotine. Rats were injected with the drug (s.c. or i.p.) and contained in the non-preferred side for 30 minutes, and on alternate days saline was administered. This procedure was repeated for three cycles (6 days). In the post-conditioning phase, rats were drug-free and were allowed free access to both compartments for 15 min. The time spent in each compartment was recorded. To further confirm our findings, we also evaluated nicotine CPP in pretreated rats \[0.5 mg/kg (s.c) for 7 days (twice a day)\].

Self-administration (SA) test
-----------------------------

Rats were contained in standard sound attenuating operant chambers with ventilation fans to reduce external noise (Coulbourn Instruments, Allen-town, Pennsylvania, USA). There was a food pellet dispenser and two response levers of 4.5 cm width in one wall of each operant chamber. Then, there were stimulus lights positioned 6 cm above each lever and a house light (2.5-W, 24-V) was sited centrally at the top of the opposite wall to illuminate the chamber. A minimal downward pressure (approximately 25 g) on a lever could cause an automated consequence. Outside the chamber, there was a motor-driven syringe pump (Coulbourn) that served to supply solution at a rate of 0.01 ml/sec, through a liquid swivel via Teflon tubing. The swivel that was positioned at the top of the chamber was mounted on a counter-balanced arm which would allow free movement of the rats. For intravenous delivery of nicotine, the tubing was connected to the catheter system of the rats. Software (Graphic State Notation, Coulbourn) was installed on a computer and used in lever training and self-administration experiment. This system controlled experimental parameters, such as schedule of reinforcements, time periods, and data collection.

Rats were trained to press a lever for a contingent pellet reward on a continuous schedule of reinforcement (30 mins/day for 3 days). Only those rats which acquired at least 100 pellets during the last session were selected and prepared for surgery. Before the surgery, they were given anesthesia. Surgical procedures and post-surgical care are described in our previous studies ([@b10-bt-22-460]; [@b12-bt-22-460]). After a 3 days recovery period, the 2-hour per day nicotine self-administration test commenced. During the first five days of self-administration, rats were placed under FR1 schedule. Subsequently, FR schedule was adjusted to FR2 for the next 3 days (6th--8th day) and FR3 for the last 2 days (9th and 10th day). During the session, two levers were present and a press on the left lever would create a cascade response: initiation of infusion pump for 10 seconds resulting to a delivery of 0.1 ml drug (0.01, 0.03, and 0.06 mg/kg nicotine), setting of a stimulus light above the left lever which remained lit for 20 seconds after the end of the infusion. Responses were also recorded during time-outs, but did not have any automated consequence. As a control for general activity, presses on the left lever were noted but not reinforced with drug infusions. To prevent from drug intoxication, rats were only allowed 3 ml infusions per session; although, lever responses were still recorded for the rest of the 2-hour session.

Determination of blood nicotine levels
--------------------------------------

HPLC system of the Nanospace SI-2 series (Shiseido, Tokyo, Japan) consisted of two 3001 Binary pumps, a 3002 UV-vis detector, a 3003 autosampler, a 3004 column oven, a 3012 high switching valve was used. The signals were processed by dsChrom-I (Donam Instrument Inc., Seoul, Korea). 200 μL serum of calibrators, controls, or samples, 50 μL trichloroacetic acid (10 g/100 mL) was vortexed for 30 seconds. Then 150 μL of washing solvent, 5% (v/v) acetonitrile in 20 mM phosphate buffer (pH 5.1) was added and vortexed for 30 s. The tubes were centrifuged at 12000 rpm for 5 min. 40 μL of the clear supernatants were injected into the HPLC for on-line solid phase extraction and analysis with an autosampler. The serum sample was pre-separated on the pre-column, Capcell Pak MF ph column (10 mm×2.0 mm I.d., Shiseido, Tokyo, Japan) with a washing solvent at flow-rate of 0.5 mL/min to remove proteins and concentrate nicotine from serum sample. The nicotine molecule fractions from first separation were transferred to a concentration column, Capcell Pak UG 120 U column (35 mm×2.0 mm I.D., Shiseido, Tokyo, Japan) and then the final separation was performed on an analytical column, Capcell Pak UG 120 U column (250 mm×1.5 mm I.D., Shiseido, Tokyo, Japan) with a mobile phase at a flow rate of 100 μL/min. The mobile phase was 10% methanol, 5% acetonitrile, 0.05% diethyl amine, 1 mM heptane sulfonate sodium in 20 mM phosphate buffer (pH 5.1). The column was maintained at 30°C and the eluent was monitored at 260 nm with UV-vis detector.

Data analysis
-------------

All results were presented as means and standard error of the mean (±S.E.M.). The conditioned place preference (CPP) data was presented as the difference in time spent in the nicotine- or saline- (for control group) paired compartment during the post-conditioning and preconditioning phases ([Fig. 1](#f1-bt-22-460){ref-type="fig"}, [2](#f2-bt-22-460){ref-type="fig"}). One way analysis of variance (ANOVA) was applied to measure effects of drug-pretreatment followed by Dunnett's posttest which compare the effects of each group versus the control group. The locomotor activity was expressed as the distanced moved, in centimeters, of the animals during the nicotine-conditioning phase of the CPP. Two-way ANOVA was used to identify effect of route, douse or interaction between the two factors. In the self-administration test the number of lever responses/presses both in the active (left) and inactive (right) lever and number of infusions obtained, during the 2-hours self-administration period, were recorded. Two-way ANOVA was employed to determine variations in lever response, day or interaction between the two factors ([Fig. 3A](#f3-bt-22-460){ref-type="fig"}). The different phases of the self-administration test were analyzed separately. If significant results were obtained, post-hoc comparisons were made using the Bonferroni's test. The accepted level of significance was set as *p*\<0.05. All statistical analyses were conducted using GraphPad Prism Version 4.01 software (California, USA).

RESULTS
=======

Route determination for the CPP test
------------------------------------

[Fig. 1](#f1-bt-22-460){ref-type="fig"} shows the behavior induced by, intraperitoneally or subcutaneously injected, nicotine in adolescent and adult rats. Although not significant, it can be gleaned from ([Fig. 1A](#f1-bt-22-460){ref-type="fig"}) that s.c. nicotine induced slightly higher CPP than i.p. nicotine. In addition, s.c. nicotine produced somewhat greater locomotor activity than i.p. injection ([Fig. 1B](#f1-bt-22-460){ref-type="fig"}).

Dose determination for the CPP test
-----------------------------------

[Fig. 2A](#f2-bt-22-460){ref-type="fig"} shows the CPP score produced by different dosages of nicotine (s.c.) in adolescent and adult rats. ANOVA showed that response to different doses of nicotine vary in adolescent \[F(7, 58)=6.009, *p*\<0.001\] but not in adult rats \[F (7, 56)=1.604, \<0.05\]. Among the dosages used, only 0.1 (q=3.941, *p*\<0.01) and 0.2 mg/kg (q=5.225, *p*\<0.001) produced significant nicotine CPP in adolescent and 0.6 mg/kg (q=2.754, *p*\<0.05) in adult rats. Similar results were observed in pretreated rats, such that 0.2 mg/kg (q=3.281, *p*\<0.01) of nicotine induced CPP in adolescent and 0.6 mg/kg (q=4.315, *p*\<0.001) in adult rats.

Dose determination for the SA test
----------------------------------

[Fig. 3A](#f3-bt-22-460){ref-type="fig"} shows the number of lever responses made by adolescent or adult rats during the 2 h/day, 10 day SA sessions under the FR1, FR2 and FR3 schedules. It can be observed that adolescent rats, especially those that are self-administering 0.03 mg/kg/infusion, significantly acquired and maintained nicotine self-administration. Under the FR1 schedule, two-way ANOVA showed significant difference in responses on the active and inactive levers \[F (1, 70)=59.04, *p*\<0.001\]. This was also observed under the FR2 \[F (1, 42)=32.64, *p*\<0.001\] and FR3 \[F(1, 28)=14.31, *p*\<0.001\] schedules. No significant variation in days or lever response x day interaction.

Determination of blood nicotine levels
--------------------------------------

[Fig. 4](#f4-bt-22-460){ref-type="fig"} shows the blood nicotine levels induced by dosages that produced nicotine CPP and SA. A single injection of 0.2 mg/kg nicotine s.c. or a session of 0.03 mg/kg/infusion nicotine SA (with a mean of 10 nicotine infusions) induced blood nicotine levels that correspond well with that of an average human smoker.

DISCUSSION
==========

In the present we have demonstrated that nicotine can produce significant CPP, at dosages of 0.1 and 0.2 mg/kg (s.c.), in adolescent and 0.6 mg/kg (s.c.), in adult rats. These results were also observed in the 7 days pretreated rats. Nicotine also induced SA at 0.03 mg/kg/infusion dose, but only in adolescent rats.

For more than thirty years, CPP remains a common choice in evaluating the rewarding effects of drugs ([@b45-bt-22-460]; [@b1-bt-22-460]; [@b44-bt-22-460]). This might be because the test is comparatively simple and easy to perform. The CPP test measures a drug's rewarding effect by analyzing it's capability to produce a change in the animal's behavior ([@b21-bt-22-460]). Numerous studies have performed nicotine CPP; however, these studies greatly differ in methodology. Other studies have reported and tested factors that can influence the expression of nicotine CPP, such as the time of injection of the drug before putting the rats to the CPP apparatus. It was observed that rats tended to give affirmative response when nicotine is injected just before putting them in the apparatus ([@b29-bt-22-460]; [@b21-bt-22-460]). Accordingly, nicotine injection 20 minutes before the test would result in a weak reaction ([@b14-bt-22-460]; [@b46-bt-22-460]; [@b21-bt-22-460]). In addition, nicotine's rewarding effects could be highly influenced by the conditioning method used (biased vs. unbiased). Most studies which used unbiased procedure have failed to observe nicotine CPP, which was attributed to the weak rewarding effects of nicotine ([@b8-bt-22-460]; [@b18-bt-22-460]). A study by ([@b21-bt-22-460]), have presented that the biased method is more efficient in tracing even minute behavioral changes caused by nicotine. These reports were considered in performing the CPP procedure in this study.

One important difference that has not yet been addressed by previous studies is the route of administration. Two of the most common routes used in previous nicotine CPP studies are subcutaneous ([@b46-bt-22-460]; [@b43-bt-22-460]; [@b42-bt-22-460]; [@b27-bt-22-460]) and intraperitoneal ([@b4-bt-22-460]; [@b19-bt-22-460]; [@b6-bt-22-460]). The intraperitoneal route was commonly used in mice ([@b47-bt-22-460]) while the subcutaneous route was usually used in rats ([@b46-bt-22-460]; [@b43-bt-22-460]; [@b42-bt-22-460]; [@b27-bt-22-460]). However, there are no definite reasons/explanations behind this practice. Although not significant, here we have observed that subcutaneously injected nicotine was better in inducing CPP and locomotor activation than intraperitoneal injection ([Fig. 1](#f1-bt-22-460){ref-type="fig"}). This observation might probably be due to pharmacokinetic differences, pharmacological effects of nicotine and absorption of the drug for both routes ([@b28-bt-22-460]; [@b40-bt-22-460]). To our knowledge, this is the first study to directly compare the rewarding effects of nicotine in these two commonly used routes.

Another important factor that could influence the expression of CPP is the dosage of the drug. Several studies presented various dosages of nicotine believed to induce place preference. For instance, [@b43-bt-22-460] described that at 0.4 and 0.6 mg/kg of nicotine could significantly stimulate place preference. Other evidences reported that an intermediate dose of nicotine (0.5--0.8 mg/kg) could initiate CPP response ([@b46-bt-22-460]; [@b37-bt-22-460]). On the contrary, ([@b36-bt-22-460]) stated that nicotine (0.06 mg/kg) failed to cause place preference. These varying results created puzzling information as to the definite nicotine dose which could significantly support place preference. In this study, we also tried to determine the nicotine dose that would effectively produce place preference by using a wide range of dose (0.05--1 mg/kg), based on dosages reported to induce CPP by previous studies ([@b13-bt-22-460]; [@b35-bt-22-460]; [@b23-bt-22-460]; [@b21-bt-22-460]). The subcutaneous route of administration was used. Results revealed that, in adolescents, 0.1 and 0.2 mg/kg dose of nicotine induced highly significant place preference. This result coincides with other published reports ([@b43-bt-22-460]; [@b49-bt-22-460]). On the other hand, adult rats showed place preference for nicotine but only in the higher dose of 0.6 mg/kg. This result is similar to that of ([@b46-bt-22-460]). However, when compared to adolescent rats, nicotine CPP in adult rats is noticeably lesser. These results highlight the disparity in response to nicotine between adolescent and adult rats, which will be further discussed below. To further confirm our CPP findings, rats were pretreated with nicotine for 7 days and then subsequent nicotine CPP was evaluated. This was based on the observation that CPP to psychostimulants are better expressed in pretreated rats ([@b33-bt-22-460]). Indeed, we have confirmed that the dose of 0.2 mg/kg is rewarding for adolescents while the 0.6 mg/kg is rewarding for adult rats.

Previous nicotine self-administration studies examined different nicotine doses and reported varying results. For instance, nicotine SA was observed at 0.03 and 0.06 mg/kg/infusion while negligible response was noticed at 0.003 mg/kg/infusion ([@b13-bt-22-460]). Contrarily, another experiment failed to produce significant nicotine SA at 0.03 mg/kg/infusion ([@b23-bt-22-460]). Hence, here we evaluated nicotine SA across a wide dose range (0.01 to 0.03 mg/kg/infusion). In line with the findings of ([@b13-bt-22-460]), here we have demonstrated that at 0.03 mg/kg/infusion rats significantly acquired and maintained nicotine SA. However, this was only observed in adolescent rats; adult rats failed and to acquire significant nicotine SA. This result supports the growing evidence that adolescents are more responsive to the reinforcing effect of nicotine.

Epidemiological studies have raised concerns that young individuals are more likely to develop nicotine addiction/dependence ([@b30-bt-22-460]). These were further supported by preclinical studies reporting that adolescents are more sensitive to the addictive effects of nicotine, but not all have observed this effect ([@b38-bt-22-460]). The present findings add to the growing evidence that adolescents are indeed more sensitive to the rewarding and reinforcing effects of nicotine. However, the exact neurobiological mechanism underlying this phenomenon is still unknown ([@b19-bt-22-460]).

Doses that produce nicotine CPP and SA in the present study produced blood nicotine levels that correspond well with human smokers ([Fig. 4](#f4-bt-22-460){ref-type="fig"}). Blood nicotine levels of smokers usually range from 10--60 ng/ml ([@b32-bt-22-460]; [@b24-bt-22-460]), with some reaching up to 100 ng/ml ([@b25-bt-22-460]). Within this range, nicotine was shown to sufficiently increase dopamine in the brain's reward system, consequently inducing reward and reinforcement ([@b5-bt-22-460]). This might explain the observed rewarding and reinforcing effects in these dosages.

In conclusion, these present findings extend and corroborate previous studies by demonstrating that nicotine exposure or pre-exposure lead to a steadfast CPP \[0.2 mg/kg dose (s.c.)\] in adolescent and \[0.6 mg/kg dose (s.c.)\] adult rats. Nicotine also supports reliable self-administration (0.03 mg/kg/infusion), but only in adolescents. These rewarding and reinforcing effects may contribute to addiction/dependence towards this drug. Moreover, the results highlight that adolescents respond more sensitively to nicotine's addictive liability. Anyhow, these findings may serve as a promising basis for future experiments on nicotine addiction. Importantly, it encourages careful monitoring of nicotine and its related substances.
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![CPP route determination. Effects of subcutaneously (s.c.) or intraperitoneally (i.p.) injected nicotine on the CPP test. (A) Both s.c and i.p. injected nicotine produced CPP at 0.1 and 0.2 mg/kg dose, but only in adolescent rats. Although not significant, the CPP induced by s.c. injected nicotine is somewhat higher than i.p. (B) The locomotor activity during the conditioning phase of CPP. Although not significant, rats injected with s.c. nicotine showed higher distance moved than those injected by i.p. The values are presented means and S.E.M. \*\**p*\<0.01, \*\*\**p*\<0.001 statistically significant vs. the control group (Dunnet's posttest).](bt-22-460f1){#f1-bt-22-460}

![CPP dose determination. (A) Nicotine (s.c.) induced CPP in adolescent and adult rats across a wide dose range. Adolescent rats showed substantially higher CPP relevant to adult rats, particularly at 0.1 and 0.2 mg/kg nicotine. Adult rats also showed CPP at 0.6 mg/kg dose. (B) As confirmation, nicotine pretreated rats (0.5 mg/kg s.c., 7 days, 2 times a day) adolescent rats still showed higher nicotine CPP score at 0.2 mg/kg while pretreated adult rats at 0.6 mg/kg. The values are presented as means and S.E.M. \**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.001 statistically significant vs. the control group (Dunnet's posttest).](bt-22-460f2){#f2-bt-22-460}

![Self-administration data. Nicotine self-administration in adolescent and adult rats. (A) The number of lever responses made or (B) infusions obtained by adolescent and adult rats during the 2 h/day, 10-days nicotine SA sessions under the FR1, FR2, and FR3 schedules. Filled symbols indicate lever responses on the active lever while unfilled symbols show responses for the inactive lever. The values are presented means and S.E.M. \**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.001 statistically significant vs. the control group (Bonferroni's posttest).](bt-22-460f3){#f3-bt-22-460}

![Blood nicotine level. Blood nicotine levels induced by dosages that produced nicotine CPP and SA. Blood nicotine levels in adolescent rats after single subcutaneous injection of 0.2 mg/kg of nicotine (CPP) or immediately after a 0.03 mg/kg/infusion nicotine SA session (mean of 10 infusions).](bt-22-460f4){#f4-bt-22-460}
